Moderna MRNA incurred a loss of $2.52 per share in the first quarter of 2025, narrower than the Zacks Consensus Estimate of a ...

diabetes or chronic obstructive pulmonary disorder should be able to get the RSV shot. A new combination vaccine from GSK was endorsed. It protects against five types of meningococcal bacteria ...

In June 2024, ACIP postponed a vote on a recommendation for adults aged 50-59 at increased risk for RSV-LRTD until additional data becomes available. The recommendation also includes GSK plc’s ...

GSK) are expected to reap benefits as an advisory committee of the CDC on Wednesday voted to expand the use of vaccines against the respiratory syncytial virus (RSV) for a broader population in ...

The ACIP has now recommended the use of GSK’s RSV vaccine, Arexvy, and PFE’s RSV vaccine, Abrysvo, in adults aged 50-59 who are at high risk of severe RSV disease. Individuals with underlying ...

The CDC had decided to hold off on recommending RSV shots for adults under age 60 last year. GSK's Arexvy and Pfizer's Abrysvo are approved for the prevention of lower respiratory tract disease ...

The reversal from the Advisory Committee on Immunization Practices (ACIP) is a potential boost for GSK and Pfizer. Both companies saw sales of their RSV vaccines for adults tumble last year after ...

GSK GSK and Pfizer PFE announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the expanded use of their ...

(Alliance News) - GSK PLC on Wednesday said it received two significant endorsements from a US advisory panel, bolstering its respiratory syncytial virus and meningitis vaccine portfolios.

(Alliance News) - GSK PLC on Wednesday said it received two significant endorsements from a US advisory panel, bolstering its respiratory syncytial virus and meningitis vaccine portfolios. The ...

GSK said two of its vaccines obtained a positive recommendation from a U.S. body, aiming at tackling meningitis and the respiratory syncytial virus. The pharmaceutical company said Thursday that ...